Arcus Biosciences, Inc.
RCUS
$10.53
$0.050.48%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 100.00% | -2,700.00% | -16.05% | -29.58% | -24.00% |
Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -18.75% | -61.11% | 0.00% | -6.25% | 0.00% |
Change in Net Operating Assets | -678.95% | 0.00% | 4.17% | 1,222.22% | -- |
Cash from Operations | -41.49% | -6,500.00% | -13.64% | 141.27% | -64.91% |
Capital Expenditure | -- | 75.00% | 83.33% | 90.00% | 100.00% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 117.46% | 120.00% | 52.94% | -233.33% | 103.23% |
Cash from Investing | 117.46% | 118.93% | 82.14% | -363.64% | 142.31% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 0.00% | -37.99% | 0.00% | -66.67% | -86.96% |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | 2,500.00% | -37.99% | -166.67% | 700.00% | -91.30% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 293.10% | -27.59% | 10.53% | 197.83% | -262.50% |